Dipyridamole 75 MG

DRUG3 trials

Sponsors

Clear Creek Bio, Inc., Stanford University, Hadassah Medical Organization

Conditions

COVID-19Hypertension ,PregnancyHypophosphatemiaKidney TransplantationPreeclampsia (PE)

Phase 1

Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects

Not yet recruitingNCT07738562

Hadassah Medical OrganizationHypertension ,Pregnancy, Preeclampsia (PE)

Start: 2026-09-01End: 2028-09-01Target: 15Updated: 2026-07-31

Phase 2

Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19

TerminatedNCT05166876

Clear Creek Bio, Inc.COVID-19

Start: 2022-02-01End: 2022-06-04Updated: 2023-11-07

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

RecruitingNCT06824454

Stanford UniversityHypophosphatemia, Kidney Transplantation

Start: 2025-05-15End: 2027-05-01Target: 90Updated: 2026-06-11